Interestingly, EGFR-STAT3 activation in myeloid cells protects mice from colitis induction by dextran sodium sulfate treatment (DDS), via regulation of IL-6 production, which prevents intestinal damage leading to IEC proliferation [67]. Here, STAT3 is linked to colitis.